Estimating the effectiveness and cost-effectiveness of a complex intervention to increase care home staff influenza vaccination rates
- Conditions
- Influenza vaccination in care home staffInfections and InfestationsInfluenza and pneumonia
- Registration Number
- ISRCTN22729870
- Lead Sponsor
- niversity of East Anglia
- Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36494824/ (added 12/12/2022) 2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37715262/ Protocol of the process evaluation (added 18/09/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 280
Care homes (CHs):
1. Registered to provide care for older residents, which may include people with dementia
2. Self-reported staff vaccination rate <40%
3. Must be signed up or willing to sign up to the DHSC Capacity Tracker and willing to submit weekly updates on flu vaccine status of staff and residents
Added 09/07/2024:
Community pharmacies:
1. Has an ongoing relationship with a care home that meets the CH inclusion/exclusion criteria
2. Willing to provide flu vaccinations within the care home to all directly employed care home staff
3. Have adequate staff available to deliver a flu vaccination clinic within the care home
1. Fewer than 10 staff members (as insufficient qualitative and quantitative data likely to be produced)
2. Participated in the FluCare feasibility trial
Added 09/07/2024:
3. Planning a flu vaccination initiative similar to the FluCare intervention
4. Participated in FluCare feasibility or randomised controlled study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Staff flu vaccination rate: the total number of staff vaccinated in a flu season over the total number of staff employed at any point throughout that flu season (all directly contracted staff (care staff, cleaners, cooks, administrative staff) + agency staff), measured using anonymised staff data logs on a monthly basis, starting at baseline for 6 months or until the end of March 2023, whichever is the earliest
- Secondary Outcome Measures
Name Time Method